Form 4: Amylyx Pharmaceuticals Chief Legal Officer Sells Shares to Cover Tax Obligations

Gina Mazzariello, Chief Legal Officer of Amylyx Pharmaceuticals, sold 2,838 shares of common stock on February 23, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 23, 2024, Gina Mazzariello, the Chief Legal Officer of Amylyx Pharmaceuticals, sold 2,838 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $18.7564, with individual transactions ranging from $18.61 to $19.02.
• Following the transaction, Mazzariello directly owns 46,245 shares of Amylyx Pharmaceuticals.
• The sale was automatic and not at the discretion of the reporting person.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) and doesn't convey any strong positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are not necessarily indicative of the executive's sentiment towards the company's future prospects.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact due to the nature of the transaction.

Key Dates